LBA28 A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial

Mansoor Raza Mirza, Line Bjørge, Frederik Marmé, René dePont Christensen, Marta Gil-Martín, Annika Auranen, Beyhan Ataseven, María Jesús Rubio, Vanda Salutari, Bente Lund, IB Runnebaum, Andrés Redondo, Kristina Lindemann, Fabian Trillsch, M.P. Barretina Ginesta, Henrik Roed, Joan Løhndorf, G-B. Nyvang, Jalid Sehouli